Literature DB >> 15610132

Early closure of a randomized controlled trial of three treatment approaches to early localised prostate cancer: the MRC PR06 trial.

.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15610132     DOI： 10.1111/j.1464-410X.2004.05224_3.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  7 in total

1.  Current prostate cancer treatment: Not what but when?

Authors:  Peter A Massaro; Ilias Cagiannos
Journal:  Can Urol Assoc J       Date:  2016-08       Impact factor: 1.862

2.  Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation.

Authors:  Amol K Narang; Carol Gergis; Scott P Robertson; Pei He; Ashwin N Ram; Todd R McNutt; Emily Griffith; Theodore A DeWeese; Stephanie Honig; Harleen Singh; Danny Y Song; Phuoc T Tran; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-31       Impact factor: 7.038

Review 3.  Can we deliver randomized trials of focal therapy in prostate cancer?

Authors:  Hashim U Ahmed; Viktor Berge; David Bottomley; William Cross; Rakesh Heer; Richard Kaplan; Tom Leslie; Chris Parker; Clare Relton; Richard Stephens; Matthew R Sydes; Lindsay Turnbull; Jan van der Meulen; Andrew Vickers; Timothy Wilt; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2014-04-22       Impact factor: 66.675

4.  Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study.

Authors:  Daniel A Barocas; Vivien Chen; Matthew Cooperberg; Michael Goodman; John J Graff; Sheldon Greenfield; Ann Hamilton; Karen Hoffman; Sherrie Kaplan; Tatsuki Koyama; Alicia Morgans; Lisa E Paddock; Sharon Phillips; Matthew J Resnick; Antoinette Stroup; Xiao-Cheng Wu; David F Penson
Journal:  J Comp Eff Res       Date:  2013-07       Impact factor: 1.744

Review 5.  Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions.

Authors:  Benjamin A Greenberger; Victor E Chen; Robert B Den
Journal:  Front Oncol       Date:  2019-11-29       Impact factor: 6.244

6.  A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study.

Authors:  L Dickinson; H U Ahmed; A P Kirkham; C Allen; A Freeman; J Barber; R G Hindley; T Leslie; C Ogden; R Persad; M H Winkler; M Emberton
Journal:  Contemp Clin Trials       Date:  2013-06-14       Impact factor: 2.261

Review 7.  Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.

Authors:  Abhishek A Solanki; Stanley L Liauw
Journal:  Open Access J Urol       Date:  2011-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.